Radiolabelled compounds
The present invention provides novel radiolabeled monoacylglycerol lipase (MAGL) inhibitors that are useful in medical imaging such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and/or radioautography. 本发明提供了新的放射性标记的单酰基甘油脂肪酶(MAGL)抑制剂,所述抑制剂可用于医学成像诸如正电子发射断层...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides novel radiolabeled monoacylglycerol lipase (MAGL) inhibitors that are useful in medical imaging such as positron emission tomography (PET), single photon emission computed tomography (SPECT), and/or radioautography.
本发明提供了新的放射性标记的单酰基甘油脂肪酶(MAGL)抑制剂,所述抑制剂可用于医学成像诸如正电子发射断层扫描(PET)、单光子发射计算机断层扫描(SPECT)和/或放射自显影。 |
---|---|
Bibliography: | Application Number: CN202080064238 |